Dyadic’s C1 Platform Selected By The Vaccine And Immunotherapy Center At Massachusetts General Hospital As Part Of VIC’s $5.88M Award By U.S. DoD To Develop A Self-Assembling Vaccine Platform For Rapid Production Of Prophylactic Vaccines
Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein
